1401450-89-2

Upstream product

• 1401449-59-9 6-bromo-N-(3,3,3-trifluoropropyl)-1H-benzimidazol-4-amine 
• 1401449-58-8 tert-butyl 6-bromo-4-[(3,3,3-trifluoropropyl)amino]-1H-benzimidazole-1-carboxylate 
• 1401449-57-7 tert-butyl 4-amino-6-bromo-1H-benzimidazole-1-carboxylate 
• 1360899-50-8 6-bromo-1H-1,3-benzodiazol-4-amine 
• 1121586-23-9 5-bromobenzene-1,2,3-triamine 
• 62554-90-9 4-bromo-2,6-dinitroaniline 
• 606-22-4 2,6-dinitroaniline 
• 201230-82-2 carbon monoxide 
• 1401449-77-1 methyl 4-{6-bromo-4-[(3,3,3-trifluoropropyl)amino]-1H-benzimidazol-1-yl}-2-methylbenzoate 
• 149507-26-6 3-fluoro-4-methoxy-phenylboronic acid 

Relevant academic research and scientific papers

SUBSTITUTED BENZIMIDAZOLES

The present invention relates to substituted benzimidazole compounds of general formula (I) in which R3, R5 and A are as defined in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.